Bionic skin technology provides advanced tactile recognition and visualization capabilities

A new publication from Opto-Electronic Advances; DOI 10.29026/oea.2025.240152, discusses how multi-photon bionic skin realizes high-precision haptic visualization for reconstructive perception.

Marinus lays off 20% of workforce, cuts costs to stay afloat

Marinus Pharmaceuticals is cutting about 20% of its workforce and making other cost-cutting changes to extend its cash runway into the first quarter of 2025.

May 9, 2024

New discovery could lead to a treatment for visceral leishmaniasis

A discovery by Simona Stäger’s team could help come up with a treatment to the most serious form of leishmaniasis.

May 21, 2024

LoQus23 secures $43m to advance Huntington’s Disease therapy – Pharmaceutical Technology

By targeting a dysfunctional DNA repair system, inhibitors could slow or halt the progression of Huntington’s disease. Image: Shutterstock/ Andrii Yalanskyi. LoQus23 closed a round

October 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.